Bacterial Metabolism under FHA Control

Bacterial Metabolism under FHA Control

Structure Previews Bacterial Metabolism under FHA Control Marco Bellinzoni1 and Pedro M. Alzari1,* 1Institut Pasteur, Unite ´ de Biochimie Structural...

57KB Sizes 0 Downloads 113 Views

Structure

Previews Bacterial Metabolism under FHA Control Marco Bellinzoni1 and Pedro M. Alzari1,* 1Institut Pasteur, Unite ´ de Biochimie Structurale, CNRS URA 2185, 25 rue du Docteur Roux, 75724 Paris, France *Correspondence: [email protected] DOI 10.1016/j.str.2009.03.004

The NMR structures of Corynebacterium glutamicum OdhI described by Barthe et al. in this issue of Structure reveal a major conformational rearrangement upon phosphorylation, suggesting an autoinhibition mechanism that accounts for the functional properties of the protein as a regulatory switch in glutamate metabolism. Reversible protein phosphorylation is probably the major mechanism of cell signaling in living cells. The formation and dissociation of protein complexes, driven by the recognition of phosphodependent interaction sites, allow the dynamic establishment of a myriad of different signal transduction pathways. While protein kinases and phosphatases are natural players in these processes, signal transduction would be impossible without the protein modules that are able to specifically bind phosphorylated residues on target proteins (Seet et al., 2006). A classic example is the SH2 (Src Homology 2) domain, considered as the prototype of signaling module specific for phosphotyrosine. Concerning the even more widespread Ser/Thr phosphorylation, a close functional homolog of the SH2 domain is the ForkHead-Associated (FHA) domain (Hofmann and Bucher, 1995), which specifically binds phosphothreonine (pThr) residues and participates in diverse biological functions (for a recent review, see Mahajan et al. [2008]). Overwhelming evidence has accumulated in the last few years about the physiological role of Ser/Thr phosphorylation, not only in eukaryotes but also in bacterial signaling processes. A clear illustration is the recent discovery that the tricarboxylic acid (TCA) cycle in C. glutamicum is posttranscriptionally regulated by the Ser/Thr protein kinase PknG through its target protein OdhI, composed of a single FHA domain with a N-terminal extension that includes the kinase substrate motif (Niebisch et al., 2006). The unphosphorylated form of OdhI binds to and inhibits OdhA, the E1 subunit of the a-ketoglutarate complex (ODH), whereas the PknG phosphorylation of OdhI relieves this inhibition (Bott, 2007; Niebisch et al., 2006). A similar control mechanism was also found to be operational in mycobacteria, where

GarA (the OdhI homolog) inhibits not only the a-ketoglutarate decarboxylase (KGD, the OdhA homolog) but also a large NAD+-specific glutamate dehydrogenase (GDH) (O’Hare et al., 2008). As in C. glutamicum, phosphorylation of GarA by PknG (or PknB, another conserved Ser/Thr protein kinase [Villarino et al., 2005}) relieves the inhibition. The two metabolic enzymes, KGD and GDH, share a-ketoglutarate as the common substrate and lie at a fundamental branching point for nitrogen metabolism; a-ketoglutarate can be either oxidized by KGD to succinic semialdehyde and re-enter the Krebs cycle in the form of succinate through the concerted action of succinic semialdehyde dehydrogenase, or be converted to glutamate by GDH and eventually to glutamine by the action of glutamine synthetase. GarA would thus act as the regulatory switch between the two pathways, redirecting the flux of a-ketoglutarate toward the production of glutamate when unphosphorylated (O’Hare et al., 2008). In this issue of Structure, Barthe et al. (2009) report the NMR structure of C. glutamicum OdhI in both the unphosphorylated and phosphorylated forms. The structure of unphosphorylated OdhI reveals the canonical 11-strands b sandwich core of the FHA domain, while the N-terminal extension of the protein (including the phosphorylatable Thr residue) is fully disordered. The phosphorylation of Thr15 promotes binding in cis of the pThr to the FHA domain, inducing the partial folding of the N-terminal extension and preventing any further interaction of the FHA with other (phospho) proteins. As observed in previous structures of FHA-phosphopeptide complexes, seven residues (centered around pThr15) are in contact with the FHA core domain, while part of the connecting peptide (residues

20-29) fold into an amphipatic a helix that makes hydrophobic contacts with the external face of FHA strands b7-b8, reinforcing the intramolecular interaction (Barthe et al., 2009). These findings suggest a novel mechanism of autoinhibition of OdhI/GarA in response to phosphorylation and suggest a model in which these small FHA proteins operate as molecular switches acting at a crucial ‘‘checkpoint’’ of glutamate metabolism in actinobacteria. Phosphorylation would be the signal triggering the switch from the ‘‘on’’ state (interacting) to the ‘‘off’’ state, characterized by the intramolecular closure of the FHA domain (Barthe et al., 2009). This model is fully consistent with the recent biophysical studies of mycobacterial GarA, which demonstrate that phosphorylation significantly increases the thermal stability of the protein as a result of the tight interaction between the FHA domain and the phosphorylated N-terminal peptide (England et al., 2009). OdhI and GarA are both specifically phosphorylated on a single Thr residue in a highly conserved ETTS motif. However, phosphorylation is site-specific and dependent on the kinase, since PknG was shown to phosphorylate the first of the two adjacent Thr residues (Niebisch et al., 2006; O’Hare et al., 2008) and PknB the second (Barthe et al., 2009; Villarino et al., 2005). The OdhI structure suggests that phosphorylation at Thr14 would promote a conformational rearrangement similar to that observed upon phosphorylation at Thr15, facilitated by the flexibility of the N-terminal region connecting the ETTS motif to the FHA domain (Barthe et al., 2009). This is in agreement with the observation that phosphorylation of the mycobacterial homolog at either of the equivalent threonine (Thr21 or Thr22) induces a comparable increase in thermal stability (England et al., 2009). Taken

Structure 17, April 15, 2009 ª2009 Elsevier Ltd All rights reserved 487

Structure

Previews together, these observations strongly suggest that the inhibitory properties of the regulator can be turned off in a similar way by different kinases transferring the phosphate group to adjacent Thr residues. This form of control of a major metabolic intermediate through the direct inhibition of different enzymes represents to our knowledge a novel function for an FHA protein, as these pThr-binding modules are usually considered as scaffolds that promote the interaction of signaling partners in response to phosphorylation. It remains to be determined whether the interaction of OdhI/GarA with the regulated enzymes depends on the FHA domain (which would likely recognize a putative phosphorylation site in the target enzyme) or on the N-terminal extension carrying the phosphorylatable threonine. The first hypothesis would not only imply a double control by Thr phos-

Belanger, A.E., and Hatfull, G.F. (1999). J. Bacteriol. 181, 6670–6678.

phorylation (at the target enzyme to create the OdhI/GarA binding site, and at the regulatory protein itself to switch off inhibition), but also suggests that OdhI/GarA might bind to and regulate additional phosphoprotein targets (in fact, GarA was initially characterized as a regulator of glycogen accumulation in Mycobacterium smegmatis [Belanger and Hatfull, 1999]). Further research work is certainly desirable to understand the interactions of OdhI/GarA with its enzyme target(s) as well as to ascertain whether this FHA protein is indeed a common regulator of different metabolic pathways in actinobacteria.

Hofmann, K., and Bucher, P. (1995). Trends Biochem. Sci. 20, 347–349.

REFERENCES

Seet, B.T., Dikic, I., Zhou, M.M., and Pawson, T. (2006). Nat. Rev. Mol. Cell Biol. 7, 473–483.

Barthe, P., Roumestand, C., Canova, M.J., Kremer, L., Hurard, C., Molle, V., and CohenGonsaud, M. (2009). Structure 17, this issue, 568–578.

Villarino, A., Duran, R., Wehenkel, A., Fernandez, P., England, P., Brodin, P., Cole, S.T., ZimnyArndt, U., Jungblut, P.R., Cervenansky, C., and Alzari, P.M. (2005). J. Mol. Biol. 350, 953–963.

488 Structure 17, April 15, 2009 ª2009 Elsevier Ltd All rights reserved

Bott, M. (2007). Trends Microbiol. 15, 417–425. England, P., Wehenkel, A., Martins, S., Hoos, S., Andre-Leroux, G., Villarino, A., and Alzari, P.M. (2009). FEBS Lett. 583, 301–307.

Mahajan, A., Yuan, C., Lee, H., Chen, E.S., Wu, P.Y., and Tsai, M.D. (2008). Sci. Signal. 1, re12. Niebisch, A., Kabus, A., Schultz, C., Weil, B., and Bott, M. (2006). J. Biol. Chem. 281, 12300–12307. O’Hare, H.M., Duran, R., Cervenansky, C., Bellinzoni, M., Wehenkel, A.M., Pritsch, O., Obal, G., Baumgartner, J., Vialaret, J., Johnsson, K., and Alzari, P.M. (2008). Mol. Microbiol. 70, 1408–1423.